Physician profile
Jennifer L Clair
NPI 1033118989
$898.65
in general payments reported to CMS, 2019-2025
18 companies · $259 in 2025
The $259 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.13 · 2020: $64.10 · 2021: $35.37 · 2022: $61.97 · 2023: $86.81 · 2024: $339 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $229.21 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $94.61 | 2019-2025 | Prolia, Evenity, Repatha |
| Pfizer INC. | $76.39 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $66.21 | 2023-2025 | |
| Glaxosmithkline, LLC. | $57.91 | 2020-2025 | Shingrix, Arexvy |
| Astellas Pharma US INC | $42.89 | 2024 | Veozah |
| Abbvie INC. | $39.95 | 2025 | |
| Lilly USA, LLC | $37.35 | 2020-2024 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $35.37 | 2020-2024 | Airsupra |
| Radius Health, INC. | $33.39 | 2024 | Tymlos |
| Boston Scientific Corporation | $30.87 | 2025 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.10 | 2019-2025 | Jardiance |
| Viiv Healthcare Company | $27.13 | 2024 | Dovato |
| Biohaven Pharmaceuticals, INC. | $23.71 | 2021 | |
| Exeltis, USA INC. | $19.72 | 2023 | Slynd |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $19.29 | 2024 | Ibsrela |
| Exact Sciences Corporation | $17.38 | 2025 | Cologuard Collection Kit |
| Ironwood Pharmaceuticals, INC | $17.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Clair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.